EUVIMEDEUVIMED entdecken
Open Access

Biosponge-Encased Placental Stem Cells for Volumetric Muscle Loss Repair

David Johnson, Amelia Ridolfo, Ryan Mueller, Megan Chermack, Julia Brockhouse, Jamshid Tadiwala, Avantika Jain, Kenneth Bertram, Koyal Garg iD

Advances in Wound Care · 2025

DOI: 10.1089/wound.2024.0077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Wound Care, 2025. Verfasst von David Johnson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Sciences and Engineering, St. Louis, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: Placenta, Regeneration, Muscle, Skeletal, Tissue Scaffolds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Volumetric muscle loss (VML) leads to permanent muscle mass and functional impairments. While mesenchymal stromal cells (MSCs) and their secreted factors can aid muscle regeneration, MSCs exhibit limited persistence in injured tissue post-transplantation. Human placental-derived stem cells (hPDSCs), sharing surface markers with MSCs, demonstrate superior regenerative potential due to their fetal origin. Previously, a biosponge (BS) scaffold was shown to augment muscle regeneration post-VML. This study aims to coapply BS therapy and hPDSCs to further enhance muscle recovery following VML. Approach: A VML defect was created by removing ∼20% of the tibialis anterior muscle mass in male Lewis rats. Injured muscles were either left untreated or treated with BS or BS-encapsulated hPDSCs cultured under normoxic or hypoxic conditions. On day 28 postinjury, peak isometric torque was measured, and the muscle was harvested for analysis.

Results

BS encapsulated hPDSCs subjected to hypoxic preconditioning persisted in larger quantities and enhanced muscle mass at day 28 postinjury. BS encapsulated hPDSCs cultured under normoxic or hypoxic conditions increased small myofibers (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaRegenerationMuscle, SkeletalTissue ScaffoldsStem Cell TransplantationAnimalsRats, Inbred LewMaleRatsFemaleHumansPregnancyMesenchymal Stem Cell Transplantation

Stichwörter der Autor:innen

biologic scaffoldhypoxiastem cellstissue engineeringtrophic factors

Autor:innen und Institutionen

  • Department of Biomedical Engineering, School of Sciences and Engineering, St. Louis, Saint Louis, Missouri, USA.
  • Department of Pharmacology and Physiology, School of Medicine, St. Louis, Saint Louis, Missouri, USA.
  • Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA.

ORCID-Profile: Koyal Garg

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Johnson, D., Ridolfo, A., Mueller, R., Chermack, M., Brockhouse, J., Tadiwala, J., Jain, A., Bertram, K., & Garg, K. (2025). Biosponge-Encased Placental Stem Cells for Volumetric Muscle Loss Repair. Advances in Wound Care. https://doi.org/10.1089/wound.2024.0077

Vancouver

Johnson D, Ridolfo A, Mueller R, Chermack M, Brockhouse J, Tadiwala J, et al. Biosponge-Encased Placental Stem Cells for Volumetric Muscle Loss Repair. Advances in Wound Care. 2025. doi:10.1089/wound.2024.0077

BibTeX
@article{Johnson2025,
  author = {Johnson, David and Ridolfo, Amelia and Mueller, Ryan and Chermack, Megan and Brockhouse, Julia and Tadiwala, Jamshid and Jain, Avantika and Bertram, Kenneth and Garg, Koyal},
  title = {Biosponge-Encased Placental Stem Cells for Volumetric Muscle Loss Repair},
  journal = {Advances in Wound Care},
  year = {2025},
  doi = {10.1089/wound.2024.0077}
}
Kostenlos starten →